跳至主要内容
临床试验/PACTR202102689928613
PACTR202102689928613Other2 期

Dietary supplementation with a synbiotic to improve growth in early life in Senegal: an individually randomised, 2 arm, open-label, controlled study of a synbiotic in infants in Kaffrine District, Senegal.

iverpool School of Tropical Medicine0 个研究点目标入组 708 人开始时间: 2020年11月12日最近更新:

试验速览

阶段
2 期
状态
Other
发起方
入组人数
708

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • 1) singleton newborn
  • 2) birth weight (BW) or current weight (if BW not known) 2000g or more
  • 3) well infant who is breastfed and has taken at least one breastfeed well
  • 4) age 1-3 days
  • 5) informed consent secured from mother/carer
  • 6) Infants of HIV positive women without known immunosuppression

排除标准

  • 1) multiple pregnancy (e.g. twin/triplets)
  • 2) suspicion or presence of any acute illness (e.g. fever, receiving treatment with antibiotics)
  • 3) congenital abnormality that might be life-threatening or impair growth
  • 4) infant with potential contraindication to synbiotic (e.g. suspected immune suppression; cardiac abnormality)
  • 5) mother unlikely to stay in study area for the duration of the study
  • 6) any health staff or study staff concerns regarding safety to participate in the trial

研究者

发起方
iverpool School of Tropical Medicine

相似试验